Lens capsule advanced glycation end products induce senescence in epithelial cells: Implications for secondary cataracts

Grace Cooksley,Mi‐Hyun Nam,Rooban B. Nahomi,Johanna Rankenberg,Andrew J. O. Smith,Yvette M. Wormstone,I. Michael Wormstone,Ram H. Nagaraj
DOI: https://doi.org/10.1111/acel.14249
IF: 11.005
2024-06-23
Aging Cell
Abstract:Advanced glycation end products (AGEs) in the posterior capsule of the lens induce senescence of lens epithelial cells (LECs). The senescent LECs secrete senescence‐associated secretory phenotype (SASP) and promote epithelial‐to‐mesenchymal transition of non‐senescent LECs. These events could potentially contribute to fibrosis during the development of posterior capsule opacification after cataract surgery in elderly patients. Posterior capsule opacification (PCO) is a common complication after cataract surgery. Residual lens epithelial cells (LECs) on the anterior lens capsule, after cataract surgery, migrate to the posterior lens capsule and undergo transdifferentiation into myofibroblast‐like cells. Those cells synthesize excessive amounts of extracellular matrix and contribute to fibrosis during PCO. Cellular senescence, a phenomenon that increases with aging, has been implicated in several fibrotic diseases. Here, we have investigated the prevalence of senescent LECs within the lens posterior capsule and the ability of advanced glycation end products (AGEs) in lens capsules to induce senescence, contributing to PCO. Aged lens capsules from pseudophakic human cadaver eyes showed the presence of senescent LECs. In human capsular bags, LECs showed an age‐dependent increase in senescence after 28 days of culture. Human LECs cultured on aged lens capsules for 3 days underwent senescence; this effect was not seen in LECs cultured on young lens capsules. Human LECs cultured on an AGE‐modified extracellular matrix (ECM‐AGEs) showed an AGE‐concentration‐dependent increase in the expression of senescence markers and reactive oxygen species (ROS) levels. Treatment with a RAGE antagonist and ROS inhibitor reduced the expression of senescence and fibrotic markers. Additionally, conditioned media from ECM‐AGEs‐treated cells induced the expression of fibrotic markers in naïve LECs. Together, these suggest that AGEs in the capsule induce senescence of LECs, which triggers the mesenchymal transition of neighboring non‐senescent LECs and contributes to PCO.
cell biology,geriatrics & gerontology
What problem does this paper attempt to address?